Drug interactions
Deutetrabenazine + Indacaterol-glycopyrronium
Severity: Minor
Deutetrabenazine and Indacaterol-glycopyrronium: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Deutetrabenazine does not prolong QT meaningfully at recommended doses, but its active metabolites can contribute to QT effects in some circumstances. Combined with indacaterol, the arrhythmic risk is small but may matter with bradycardia or electrolyte disturbances.
What this interaction means in plain words
Deutetrabenazine and Indacaterol-glycopyrronium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Deutetrabenazine belongs to Central Nervous System; Indacaterol-glycopyrronium belongs to Respiratory.
Why it happens
Possible small additive QT effects with beta2-agonist cardiac effects.
What to do
No routine change; check ECG and electrolytes if other QT risk factors are present.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Deutetrabenazine and Indacaterol-glycopyrronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Other interactions of Deutetrabenazine
- Deutetrabenazine + Isocarboxazid Contraindicated
- Deutetrabenazine + Linezolid Contraindicated
- Deutetrabenazine + Phenelzine Contraindicated
- Deutetrabenazine + Rasagiline Contraindicated
- Deutetrabenazine + Safinamide Contraindicated
- Deutetrabenazine + Selegiline Contraindicated
Frequently asked questions
Can I take Deutetrabenazine with Indacaterol-glycopyrronium?
MediHelp rates the interaction as minor. Deutetrabenazine and Indacaterol-glycopyrronium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Deutetrabenazine does not prolong QT meaningfully at recommended doses, but its active metabolites can contribute to QT effects in some circumstances. Combined with indacaterol, the arrhythmic risk is small but may matter with bradycardia or electrolyte disturbances.
How serious is the interaction between Deutetrabenazine and Indacaterol-glycopyrronium?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change; check ECG and electrolytes if other QT risk factors are present.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
